 Trikatu is an ancient formula made up of the three herbs Pippali (Piper longum), Maricha (Piper nigram), and Sunthi ( Zingiber officinale ) in equal ratios.
Pippali is a powerful stimulant for both the digestive and respiratory systems. It is regarded as the natural appetizer due to its actions on the digestive system. It is sturdily heating and removes cold, jamming, and revitalizes weak organic functions. It is a rejuvenative for the lungs and Kapha. It is also considered as an aphrodisiac and strengthens reproductive functions, warming and energizing the reproductive organs.
Trikatu is anti-mucus and digestive powder used to perks up gastric and respiratory function. It is helpful in cases of obesity, indigestion, high cholesterol, high triglycerides, hypo-thyroid, slow metabolism, congestion, cough and edema.
| Packs |
Retail Price |
Shipping |
Order Now |
 |
|
|
|
|
Serving size: 2 Vegi caps
Servings per container: 30
Each 500 mg capsule contains: Trikatu (All 3 herbs in proportion)
Dosage: 1-2 Capsules two times a day after meal or or as directed by your health practitioner.
Trikatu is a Sanskrit word that means “three pungent herbs”. It is the main stimulant compound used by Ayurvedic physician. Containing fruits of black pepper (Piper nigrum), long pepper (Piper longum) and the dried rhizomes of ginger (Zingiber officinalis), in equal ratio is a common amalgamation used to stimulate and maintain the digestive and respiratory systems of the body. This is done by reducing Kapha (water and earth mahabhoota) and increasing Pitta (fire mahabhoota) through the rejuvenation of low Agni (fire or jatharagni) and the eradicating away of Ama (toxins). It is sturdily heating and removes cold, congestion, reviving weak organic functions. It also works as an aphrodisiac and strengthens reproductive functions, warming, and energizing the reproductive organs.
Trikatu is a safe digestive stimulant and a powerful expectorant. It is anti-allergenic, carminative, anti-flatulent, and acts as natural anti-histamine. It is effective in dyspepsia; it provides a balanced heat to warm digestion and circulation and to prevent the formation of gastric mucosa. Trikatu is used internally in the treating gastric and abdominal disorders, asthma, bronchitis, coughs, dysentery, pyrexia, and insomnia.
Its administration promotes the emission of digestive juices, increasing appetite. Trikatu stimulates the formation of hydrochloric acid. It helps to inhibit gaseous distension.
It is prescribed as an essential part of many multi herb Ayurvedic preparations, as it has been shown to boost the bioavailability of nutrients, foods, and medicines. It promotes fast absorption of nutrients by the gastrointestinal tract. Its thermo-genic effect, metabolic enhancement, and nutrient bio-availability enhancing properties render Trikatu chiefly beneficial in the support of respiratory health.
Trikatu is preferably taken one hour before each meal in a dose of ½ to 1 teaspoon. It can also be taken along with or after a meal. As Trikatu has a pungent taste, it is better taken mixed with honey in a thick paste that can be licked.
- Promote healthy digestion, improves all gastric function
- Increase food absorption
- Reduce congestion in the digestive tract
- Recommended for poor digestion and poor appetite
- Recommended for improving lung function
- Reduce excess weight, increase vitality, and maintain balance and health.
Research I - An Ayurvedic formulation 'Trikatu' and its constituents. By Johri RK, Zutshi U.
Research was conducted at Regional Research Laboratory, Jammu-Tawi, India. 'Trikatu' is a classical Ayurvedic preparation containing black pepper (Piper nigram), long pepper (piper longum) and ginger ( Zingiber officinale), which is prescribed routinely for a variety of diseases as part of a multi-drug prescription. These herbs along with piperine (alkaloid of peppers) have been shown to possess diverse biological activities in mammalian tissue systems. An evaluation is presented of these studies and it has been suggested that their use in the Indian system of medicine could be due to their bio-availability enhancing action on other medicaments.
Research II - Effect of an indigenous herbal compound preparation 'Trikatu' on the lipid profiles of atherogenic diet and standard diet fed Rattus norvegicus.
By Valsala Sivakumar, Sivakumar, S.
T he research was carried out at Department of Zoology, Annamalai University, Annamalai nagar, Tamil Nadu, India. Combating heart related diseases is one of the tough problems of biomedical science today. Towards this goal an indigenous preparation 'Trikatu' (an herbal combination containing Piper longum (fruit), Piper nigrum (fruit) and Zingiber officinale (sunthi) dry powder was fed to normal and cholesterol fed male Rattus norvegicus to ascertain its efficacy as a hypolipidaemic agent. The effect of “Trikatu” effects on body weight, blood and tissue (aortic, cardiac and hepatic) lipids total, free and esterified cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol, triglycerides and phospholipids - and the atherogenic index were calculated. It was found that 'Trikatu' by virtue of its ability to reduce triglycerides and LDL or low density lipoprotein cholesterol and to increase HDL or high density lipoprotein cholesterol can reduce the risk of hyper-lipidaemia and atherosclerosis. Hence 'Trikatu' can be used as a potent hypo-lipidaemic agent and it can decrease the atherosclerosis linked with a high fat diet.
Research III - Effect of trikatu, an Ayurvedic prescription, on the pharmacokinetic profile of rifampicin in rabbits
By R. S. Karan, V. K. Bhargava and S. K. Garg
The research was carried out at Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. The effect of single and multiple doses of an herbal preparation “Trikatu”, an Ayurvedic prescription, on the bio-availability and pharmacokinetics of rifampicin was studied in rabbits. Rabbits ( n=10) were managed a single dose of rifampicin (24 mg/kg, p.o.) alone or in combination with a single dose of “Trikatu” (500 mg/kg, p.o.). The research had a cross over design with a washout period of 1 week. In the other study, 6 rabbits were administered a single dose of rifampicin (24 mg/kg, p.o.) before and after multiple doses of “Trikatu” (500 mg/kg×7d, p.o.). In both studies, blood samples were collected at 0, 0.5, 1, 1.5, 2, 4, 6, 9 and 12 h after drug management and assayed for rifampicin. In animals treated with single dose of trikatu there was a significant decrease in the peak plasma concentration (C max) of rifampicin (P<0.05). Multiple doses of “Trikatu” also reduced the C max and delayed the T max of rifampicin although not to a statistically noteworthy level. Other pharmacokinetic limitations of rifampicin were not considerably altered. Our results suggest that co administration of “Trikatu” does not influence the extent of bio-availability (AUC 0−α) but reduces the rate of bio-availability (C max) of rifampicin. And this latter effect may reduce the effectiveness of rifampicin therapy.
|
MY CART 
CHECKOUT
